Jennifer L Whitwell Selected Research

Apraxias (Dyspraxia)

9/2020	Ioflupane 123I (DAT scan) SPECT identifies dopamine receptor dysfunction early in the disease course in progressive apraxia of speech.
1/2020	Longitudinal flortaucipir ([18F]AV-1451) PET imaging in primary progressive apraxia of speech.
1/2018	Disrupted functional connectivity in primary progressive apraxia of speech.
1/2016	Clinical and MRI models predicting amyloid deposition in progressive aphasia and apraxia of speech.
11/2014	APOE ε4 influences β-amyloid deposition in primary progressive aphasia and speech apraxia.
5/2010	Fluorodeoxyglucose F18 positron emission tomography in progressive apraxia of speech and primary progressive aphasia variants.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jennifer L Whitwell Research Topics

Disease

37	Alzheimer Disease (Alzheimer's Disease) 06/2022 - 04/2007
35	Atrophy 06/2022 - 01/2006
16	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2022 - 01/2004
15	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2022 - 06/2006
13	Dementia (Dementias) 01/2022 - 04/2007
12	Frontotemporal Dementia (Semantic Dementia) 01/2021 - 11/2006
9	Tauopathies 01/2022 - 09/2015
9	Primary Progressive Aphasia 12/2019 - 05/2010
8	Cognitive Dysfunction 01/2021 - 12/2008
8	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 04/2007
7	Disease Progression 01/2021 - 06/2006
7	Corticobasal Degeneration 11/2020 - 06/2006
6	Apraxias (Dyspraxia) 09/2020 - 05/2010
6	Aphasia (Dysphasia) 01/2020 - 12/2013
5	Parkinsonian Disorders (Parkinsonism) 01/2022 - 02/2016
3	Pick Disease of the Brain (Pick's Disease) 11/2020 - 09/2005
3	Hippocampal Sclerosis 01/2020 - 01/2017
2	Lewy Body Disease (Lewy Body Dementia) 01/2021 - 05/2020
2	Memory Disorders (Memory Loss) 01/2019 - 01/2014
2	Amyloid Plaque 01/2019 - 07/2008
2	Language Disorders (Language Disorder) 11/2014 - 03/2014
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 07/2014 - 03/2012
1	Vascular Diseases (Vascular Disease) 01/2022
1	Neuroinflammatory Diseases 01/2021
1	Anomia (Dysnomia) 01/2021
1	Proteostasis Deficiencies 01/2020
1	Meningioma (Meningiomas) 12/2017
1	Seizures (Absence Seizure) 05/2016
1	Psychotic Disorders (Schizoaffective Disorder) 05/2016
1	Neoplasms (Cancer) 05/2016
1	Pseudobulbar Palsy 02/2016
1	Paralysis (Palsy) 02/2016
1	Parkinson Disease (Parkinson's Disease) 01/2016
1	Sarcoma (Soft Tissue Sarcoma) 01/2012
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2008
1	Multiple Sclerosis 08/2008
1	Epilepsy (Aura) 08/2008
1	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2006

Drug/Important Bio-Agent (IBA)

23	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2013
19	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2008
18	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2004
17	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2022 - 01/2012
13	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2022 - 12/2017
13	Amyloid beta-PeptidesIBA 01/2021 - 02/2008
9	Apolipoproteins E (ApoE)IBA 06/2022 - 11/2014
7	ApolipoproteinsIBA 06/2022 - 01/2014
7	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022 - 05/2010
7	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2020 - 12/2013
6	UbiquitinIBA 02/2008 - 09/2005
5	Biological ProductsIBA 01/2021 - 01/2004
4	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2015 - 01/2009
4	ProgranulinsIBA 01/2015 - 03/2007
3	LigandsIBA 01/2019 - 07/2017
2	Protein Isoforms (Isoforms)IBA 01/2022 - 10/2021
2	SynucleinsIBA 01/2022 - 01/2021
2	Levodopa (L Dopa)FDA LinkGeneric 01/2019 - 02/2016
2	alpha-SynucleinIBA 01/2017 - 09/2005
1	IronIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	Neuroprotective AgentsIBA 10/2021
1	ioflupaneIBA 09/2020
1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 09/2020
1	Dopamine Receptors (Dopamine Receptor)IBA 09/2020
1	aspartyl- arginyl- valyl- tyrosyl- isoleucyl- histidyl- prolyl- phenylalanyl- histidyl- leucyl- valyl- isoleucyl- histidine (hTDP)IBA 05/2020
1	Prostaglandins FIBA 01/2020
1	Dopamine (Intropin)FDA LinkGeneric 07/2017
1	Apolipoprotein E4IBA 01/2017
1	SteroidsIBA 05/2016
1	PrionsIBA 04/2016
1	AD 20 (AD-20)IBA 03/2011
1	N 30IBA 01/2009
1	DNA (Deoxyribonucleic Acid)IBA 01/2009
1	Protons (Proton)IBA 12/2008
1	HydrogenIBA 07/2008
1	Inositol (Myoinositol)IBA 07/2008
1	CreatineIBA 07/2008
1	N-acetylaspartate (N-acetyl aspartate)IBA 07/2008
1	Pharmaceutical PreparationsIBA 06/2006
1	tau Proteins (tau Protein)IBA 01/2004

Therapy/Procedure

5	Therapeutics 01/2021 - 04/2008
1	Activities of Daily Living (ADL) 01/2016
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 12/2011